Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Enpro | NPO | 30. jan 2025 | 186.74 | +2.10 |
Enservco | ENSV | 30. jan 2025 | 0.04 | -12.71 |
Enstar Group | ESGR | 30. jan 2025 | 327.62 | +0.04 |
Enstar Group Depository E Pref | ESGRO | 30. jan 2025 | 20.75 | -0.14 |
Enstar Pref | ESGRP | 30. jan 2025 | 20.83 | -0.43 |
Ensysce Biosciences | ENSC | 30. jan 2025 | 6.71 | -3.17 |
Entegris | ENTG | 30. jan 2025 | 101.73 | +3.81 |
Entera Bio | ENTX | 30. jan 2025 | 2.33 | -2.10 |
Entergy | ETR | 30. jan 2025 | 81.18 | +2.45 |
Entergy Texas A Pref | ETI- | 30. jan 2025 | 24.29 | +1.42 |
Entergy Utility Enterprises | EMP | 30. jan 2025 | 21.57 | +0.23 |
Entero Therapeutics | ENTO | 30. jan 2025 | 0.50 | -0.02 |
Enterprise Bancorp | EBTC | 30. jan 2025 | 42.74 | +1.26 |
Enterprise Financial Services | EFSC | 30. jan 2025 | 60.12 | +0.30 |
Enterprise Financial Services A Pref | EFSCP | 30. jan 2025 | 19.95 | -1.04 |
Enterprise Products Partners LP Unit | EPD | 30. jan 2025 | 34.04 | +1.16 |
Entrada Therapeutics | TRDA | 30. jan 2025 | 13.37 | +0.83 |
Entravision Communications | EVC | 30. jan 2025 | 2.25 | -3.43 |
Envela | ELA | 30. jan 2025 | 7.04 | +1.73 |
Enveric Biosciences | ENVB | 30. jan 2025 | 3.90 | -9.30 |
Enviri | NVRI | 30. jan 2025 | 9.73 | +3.84 |
Environmental Svcs ETF Market Vectors | EVX | 30. jan 2025 | 179.16 | +1.97 |
Envirotech Vehicles | EVTV | 30. jan 2025 | 0.35 | -48.05 |
Envista | NVST | 30. jan 2025 | 21.41 | +0.19 |
Envoy Medical A | COCH | 30. jan 2025 | 1.63 | +4.49 |
enVVeno Medical | NVNO | 30. jan 2025 | 3.28 | +4.13 |
Enzo Biochem | ENZ | 30. jan 2025 | 0.60 | -4.87 |
EOG Resources | EOG | 30. jan 2025 | 129.78 | -0.35 |
EON Resources A | EONR | 30. jan 2025 | 0.91 | +1.09 |
Eos Energy Enterprises | EOSE | 30. jan 2025 | 5.81 | +6.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.